30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Sims Karen

Insider profile

Performance

Overall performance
2.4

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 1% 68% 82%
Transactions
4 75% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return 12%
Success rate 73%
Average holding period 220
Transactions 28
Sims Karen's trades of Arbutus Biopharma Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-05 2025-02-04 PlS Planned sale
52,230 -20.6%
468.25
US$681,250
52,230 -20.6% 468.25 US$681,250
2025-02-04 2025-02-04 PrS Proposed sale
74,508
111.17
US$2,541,873
74,508 111.17 US$2,541,873
2024-07-03 2024-07-01 B Purchase
95,230
369.97
£4,379,931
95,230 369.97 £4,379,931
2024-02-05 2024-02-02 PlS Planned sale
4,358 -3.4%
2.31
US$10,078
4,358 -3.4% 2.31 US$10,078
2023-12-11 2023-12-08 S Sale
8,259
2.88
£23,782
8,259 2.88 £23,782
2023-11-29 2023-11-27 B Purchase
28
2.84
£79
28 2.84 £79
2023-06-28 2023-06-26 B Purchase
60
2.50
£150
60 2.50 £150